Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Cell Metab ; 23(5): 797-810, 2016 05 10.
Artículo en Inglés | MEDLINE | ID: mdl-27166944

RESUMEN

While leptin is a well-known regulator of body fat mass, it remains unclear how circulating leptin is sensed centrally to maintain energy homeostasis. Here we show that genetic and pharmacological ablation of adult NG2-glia (also known as oligodendrocyte precursors), but not microglia, leads to primary leptin resistance and obesity in mice. We reveal that NG2-glia contact the dendritic processes of arcuate nucleus leptin receptor (LepR) neurons in the median eminence (ME) and that these processes degenerate upon NG2-glia elimination, which explains the consequential attenuation of these neurons' molecular and electrical responses to leptin. Our data therefore indicate that LepR dendrites in the ME represent the principal conduits of leptin's anorexigenic action and that NG2-glia are essential for their maintenance. Given that ME-directed X-irradiation confirmed the pharmacological and genetically mediated ablation effects on body weight, our findings provide a rationale for the known obesity risk associated with cranial radiation therapy.


Asunto(s)
Leptina/metabolismo , Eminencia Media/metabolismo , Neuroglía/metabolismo , Envejecimiento/efectos de los fármacos , Envejecimiento/metabolismo , Animales , Anorexia/metabolismo , Núcleo Arqueado del Hipotálamo/efectos de los fármacos , Núcleo Arqueado del Hipotálamo/metabolismo , Peso Corporal/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Citarabina/farmacología , Dendritas/efectos de los fármacos , Dendritas/metabolismo , Fenómenos Electrofisiológicos/efectos de los fármacos , Femenino , Eliminación de Gen , Masculino , Eminencia Media/efectos de los fármacos , Ratones , Microglía/efectos de los fármacos , Microglía/metabolismo , Mitosis/efectos de los fármacos , Obesidad/metabolismo , Obesidad/patología , Fenotipo , Receptores de Leptina/metabolismo , Transducción de Señal/efectos de los fármacos , Aumento de Peso/efectos de los fármacos
2.
PLoS One ; 8(10): e78236, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24205170

RESUMEN

Accumulating evidence suggests that the adult murine hypothalamus, a control site of several fundamental homeostatic processes, has neurogenic capacity. Correspondingly, the adult hypothalamus exhibits considerable cell proliferation that is ongoing even in the absence of external stimuli, and some of the newborn cells have been shown to mature into cells that express neuronal fate markers. However, the identity and characteristics of proliferating cells within the hypothalamic parenchyma have yet to be thoroughly investigated. Here we show that a subset of NG2-glia distributed throughout the mediobasal hypothalamus are proliferative and express the stem cell marker Sox2. We tracked the constitutive differentiation of hypothalamic NG2-glia by employing genetic fate mapping based on inducible Cre recombinase expression under the control of the NG2 promoter, demonstrating that adult hypothalamic NG2-glia give rise to substantial numbers of APC+ oligodendrocytes and a smaller population of HuC/D+ or NeuN+ neurons. Labelling with the cell proliferation marker BrdU confirmed that some NG2-derived neurons have proliferated shortly before differentiation. Furthermore, patch-clamp electrophysiology revealed that some NG2-derived cells display an immature neuronal phenotype and appear to receive synaptic input indicative of their electrical integration in local hypothalamic circuits. Together, our studies show that hypothalamic NG2-glia are able to take on neuronal fates and mature into functional neurons, indicating that NG2-glia contribute to the neurogenic capacity of the adult hypothalamus.


Asunto(s)
Antígenos/metabolismo , Hipotálamo/metabolismo , Neuroglía/metabolismo , Neuronas/metabolismo , Proteoglicanos/metabolismo , Animales , Antígenos/genética , Biomarcadores/metabolismo , Bromodesoxiuridina/metabolismo , Diferenciación Celular/genética , Proliferación Celular/genética , Integrasas/genética , Integrasas/metabolismo , Masculino , Ratones , Células-Madre Neurales/metabolismo , Oligodendroglía/metabolismo , Regiones Promotoras Genéticas/genética , Proteoglicanos/genética , Factores de Transcripción SOXB1/genética , Factores de Transcripción SOXB1/metabolismo
3.
Glia ; 61(10): 1735-47, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23918524

RESUMEN

NG2-glia are known to proliferate in the adult brain, however the extent of their mitotic and regenerative capacity and particularly their adult origin is uncertain. By employing a paradigm of mitotic blockade in conjunction with genetic fate tracing we demonstrate that intracerebroventricular mitotic blocker infusion leads to wide-spread and complete ablation of NG2-glial cells in the hypothalamus and other periventricular brain regions. However, despite the extensive glia loss, parenchymal NG2-glia coverage is fully restored to pretreatment levels within two weeks. We further reveal that in response to mitotic blocker treatment, NG2-glia bordering the ablated territories start to express the stem cell marker nestin, divide and migrate to replace the lost cells. Importantly, the migration front of repopulating NG2-glia invariably proceeds from the distal parenchyma towards the ventricles, ruling out contributions of the subventricular zone neurogenic niche or the corresponding area of the third ventricle as source of new NG2-glia. NG2-CreER-based fate tracing further substantiates that NG2-glia which have been spared from mitotic blockade are the sole source of regenerating NG2-glia. Collectively, our data reveals that all adult NG2-glia retain the ability to divide and that they are capable of fully restoring parenchymal NG2-glia coverage after wide-spread NG2 cell loss, indicating complete self-sufficiency in maintaining NG2-glia population levels in the adult brain.


Asunto(s)
Antígenos/metabolismo , Diferenciación Celular/fisiología , Neuroglía/fisiología , Proteoglicanos/metabolismo , Regeneración/fisiología , Animales , Antígenos/genética , Bromodesoxiuridina , Antígenos CD13/metabolismo , Muerte Celular/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/genética , Ventrículos Cerebrales/citología , Ventrículos Cerebrales/efectos de los fármacos , Citarabina/toxicidad , Regulación de la Expresión Génica/efectos de los fármacos , Hipotálamo/citología , Hipotálamo/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Transgénicos , Nestina/metabolismo , Proteoglicanos/genética , ARN Mensajero/metabolismo , Regeneración/efectos de los fármacos , Regeneración/genética , Tamoxifeno/toxicidad , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...